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Abstract
Background:  Accurate quantification of DNA using quantitative real-time PCR at low levels is
increasingly important for clinical, environmental and forensic applications. At low concentration levels
(here referring to under 100 target copies) DNA quantification is sensitive to losses during preparation,
and suffers from appreciable valid non-detection rates for sampling reasons. This paper reports studies on
a real-time quantitative PCR assay targeting a region of the human SRY gene over a concentration range
of 0.5 to 1000 target copies. The effects of different sample preparation and calibration methods on
quantitative accuracy were investigated.
Results: At very low target concentrations of 0.5–10 genome equivalents (g.e.) eliminating any replicates
within each DNA standard concentration with no measurable signal (non-detects) compromised
calibration. Improved calibration could be achieved by eliminating all calibration replicates for any
calibration standard concentration with non-detects ('elimination by sample'). Test samples also showed
positive bias if non-detects were removed prior to averaging; less biased results were obtained by
converting to concentration, including non-detects as zero concentration, and averaging all values.
Tube plastic proved to have a strongly significant effect on DNA quantitation at low levels (p = 1.8 × 10-
4). At low concentrations (under 10 g.e.), results for assays prepared in standard plastic were reduced by
about 50% compared to the low-retention plastic. Preparation solution (carrier DNA or stabiliser) was
not found to have a significant effect in this study.
Detection probabilities were calculated using logistic regression. Logistic regression over large
concentration ranges proved sensitive to non-detected replicate reactions due to amplification failure at
high concentrations; the effect could be reduced by regression against log (concentration) or, better, by
eliminating invalid responses.
Conclusion: Use of low-retention plastic tubes is advised for quantification of DNA solutions at levels
below 100 g.e. For low-level calibration using linear least squares, it is better to eliminate the entire
replicate group for any standard that shows non-detects reasonably attributable to sampling effects than
to either eliminate non-detects or to assign arbitrary high Ct values. In calculating concentrations for low-
level test samples with non-detects, concentrations should be calculated for each replicate, zero
concentration assigned to non-detects, and all resulting concentration values averaged. Logistic regression
is a useful method of estimating detection probability at low DNA concentrations.
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Background
Accurate measurement of DNA using quantitative real-
time PCR (Q-PCR) techniques is fundamental to many
molecular tests with clinical [1], environmental [2], and
forensic applications [3]. Quantitative DNA analysis at
high target concentration is reproducible [4], but demand
for increasing sensitivity requires low levels of DNA to be
measured with equal reliability. This presents a challenge
to analysts as there are numerous problems associated
with trace detection and quantification, yet a range of sec-
tors are increasingly reliant on low level analyses. Clini-
cally there is growing interest in quantifying levels of
circulating nucleic acids for a range of applications includ-
ing diagnosis and monitoring of cancer patients [5], prog-
nosis for victims of trauma [6] and non-invasive prenatal
diagnosis [7]. Similarly, forensic laboratories are often
presented with extremely small amounts of material cru-
cial to a legal case; accurate analysis must then be carried
out at the first attempt as often there is insufficient sample
for repeated investigations [8]. Additionally at an interna-
tional level, legislation governing the limits for genetically
modified organisms (GMOs) in foods necessitates the use
of sensitive and accurate methods to detect and quantify
trace levels of GMO ingredients [9].
Quantification is initially reliant upon having suitable
standards in the appropriate concentration range and of
the same quality as the samples being analysed. The cho-
sen DNA standard must itself be quantified either by spec-
trophotometer, which has limitations [10] or with an
intercalating dye such as PicoGreen® [11,12] before being
used to prepare standard curves. There are currently no
certified reference materials available for DNA quantifica-
tion, so accuracy depends on the way in which individual
laboratories measure and prepare the DNA standard.
Dilution protocols involved in constructing standard
curves are recognised as contributing to reduced reliability
at low template concentrations [13,14] and there are sev-
eral causes for this. Firstly the stochastic distribution of
molecules means that at very low copy number a sam-
pling error can be introduced when pipetting aliquots of
DNA. Measurement variability at low DNA concentration
has been demonstrated by the observation that the confi-
dence intervals (representing the measurement uncer-
tainty) associated with amplification from small initial
copy numbers of template are much greater than those
with large initial copy numbers [15]. Increasing the
number of replicate analyses performed on low concen-
tration standards and samples can mitigate inaccuracy
caused by this inherent variability, and improve analytical
sensitivity [16]. A second issue is the apparent lability of
DNA when stored in solution at low concentrations,
which can significantly affect the accuracy of quantifica-
tion if dilution series are stored for prolonged periods
prior to use. A report by Teo et al. [4] highlighted the short
time scale over which fluctuations in the concentration of
standard solutions can occur, due to DNA binding to
untreated microcentrifuge tube walls. This is of particular
significance at low concentrations when there are only a
small number of molecules present and has ramifications
for the quantification of unknown samples. The result of
all these factors is that large measurement uncertainty is
associated with trace-level DNA quantification [10] and
the performance characteristics of PCR-based assays at
low target concentrations are ill defined.
The measured instrument response for Q- PCR is the Ct
value, which is the amplification cycle at which the fluo-
rescent signal from each reaction increases above a nomi-
nal threshold value. An additional problem when
working with Q-PCR at trace level is the occurrence of
valid negative reactions (here referred to as non-detects),
which do not have a quantitatively meaningful Ct value,
as the fluorescent signal does not reach the threshold level
during the course of the reaction. These are valid negative
reactions, reflecting true absence of analyte because of
sampling variability at low target concentration. Such neg-
ative results are either arbitrarily awarded a value equal to
the number of amplification cycles run (here a Ct of 55),
or are not allocated a measurable value. Assigning a value
equal to the total number of cycles run causes difficulties
in subsequent data analysis as the value will vary depend-
ent on cycling parameters, and is often identified as an
outlier value by normal statistical analysis. The non-nor-
mal distribution of results around zero generated by real-
time data has also been noted by other researchers [17]. A
common practice is to exclude all such negative reactions
entirely from the analysis, whether obtained from
unknown samples or standards. However at trace levels
the non-amplification provides accurate information
about the low concentration analytes, reflecting both the
distribution of molecules and sampling effects. Selective
omission of negative observations in these circumstances
can generally be expected to lead to biased quantification.
The purpose of this investigation was to identify measures
to increase the reliability of low level DNA quantification
and detection by Q-PCR. Firstly, we performed a series of
experiments to assess practical interventions for DNA
standard preparation, which could potentially reduce the
variability of low concentration DNA solutions and make
construction of calibration curves more accurate. This
involved preparing DNA dilutions in different types of
plastic ware and with a range of diluents. Using the results
from these experiments, we explored data handling
approaches for standard curve construction and sample
quantification, with particular attention to the treatment
of valid negative observations. Finally, routes to assessing
detection probability for characterising analytical sensitiv-
ity and performance in qualitative applications wereBMC Biotechnology 2006, 6:33 http://www.biomedcentral.com/1472-6750/6/33
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examined. Logistic regression was applied to determine
the detection probability of analyte at a particular concen-
tration, and calculations based on binomial statistics
developed to aid prediction of the degree of replication
required to achieve a particular level of sensitivity.
Results and discussion
Effect of standard DNA preparation on quantification
The effect of different standard preparation conditions
was assessed by analysis of z-scores for estimated concen-
tration, calculated as described below (see Methods,
where the rationale for z-scoring is also presented). The
estimated concentrations were calculated using calibra-
tion curves calculated using the exclusion-by-sample
method described below (see Construction of calibration
curves, below). Note that z-scores are expected to have
mean 0 and variance 1. In the scheme used here, negative
z-scores correspond to lower than average concentration
compared to the average for the group. When normally
distributed, 95% of z-scores are expected to be within
approximately ± 2.
One-way ANOVA of the z-scores for between-plate differ-
ences showed a strongly significant effect (p-value = 6.1 ×
10-7) (confirmed by a Kruskal-Wallis test (K-W) p-value of
3.4 × 10-6). This presented a choice; re-calculate concen-
trations by fitting plate by plate, or, equivalently with no
Condition/Plate interaction term, take advantage of the
balanced design and treat Plate as a blocking factor. Block-
ing by plate is the preferred option, as it naturally adjusts
for the Plate effect on the residual degrees of freedom,
which would otherwise be slightly overestimated. Graph-
ical inspection indicated that the Plate effect was not large
enough to raise concerns about level-dependent differ-
ences in variance, and two-way ANOVA confirmed that
there was no significant interaction (at the 95% level of
confidence) between Plate and Condition, so the analysis
reported here used blocking by plate. The relatively small
Plate effect also permitted continued application of the K-
W test as a follow-up test, as the Plate effect has the prac-
tical effect of increasing within-group variance and conse-
quently will tend to produce more conservative p-values
for the K-W test. To check the effect of separate construc-
tion of calibration curves for each plate, the analysis was
repeated after separate calibration by plate, with no effect
on the conclusions and only marginal effects on p-values.
We also examined the effect of simply scaling by robust
standard deviation at each concentration without z-scor-
ing (while treating Concentration as an error term); again,
this had no effect on the conclusions.
"Condition" (Table 1) was a combination of tube plastic
(low-retention and standard) and solution (tissue culture
water, stabilising solution, and carrier DNA). Initial anal-
ysis sought a general Condition effect. ANOVA for Condi-
tion effects, blocked by Plate, gave a significant between-
condition effect (p = 0.007), supported by the K-W test p-
value of 0.03 (similar, in fact, to the p-value of 0.01 for
one-way ANOVA without blocking). Homogeneity of z-
score variance across Conditions was poor, but not grossly
so; Levene's test gave a p-value of 0.035, warranting cau-
tion, but unlikely to prejudice the ANOVA results greatly.
Inspection of the z-scores by Condition (Figure 1) showed
that conditions 1–3 appeared low compared to Condi-
tions 4–6. This was potentially important since Condi-
tions 1–3 used standard plastic tubes, and 4–6 used low-
retention tubes. Otherwise, no specific group stands out.
However, given a significant Condition effect, Plastic and
Solution effects were investigated further.
Tube plastic proved to be strongly significant (p = 1.8 × 10-
4) (K-W p-value = 0.002). Inspection showed, as might be
expected, that low-retention plastic ware gave higher
Table 1: Preparation of DNA standards. Details of the conditions used in preparation of the serial dilution DNA solutions for standard 
curve construction.
Method DNA Standard preparation condition
1 Standard plastics (1.5 ml microtubes, Alpha).
Water as diluent (Tissue culture water, Sigma, UK).
2 Standard plastics.
Stabilising solution as diluent (Stabilising component for DNA standards, Cambio, UK).
3 Standard plastics.
Carrier DNA as diluent (Herring Sperm DNA, Sigma, UK @ 10 μg/ml).
4 Low retention plastics (Non-stick hydrophobic microtubes 1.5 ml, Alpha).
Water as diluent.
5 Low retention plastics.
Stabilising solution as diluent.
6 Low retention plastics.
Carrier DNA as diluent.BMC Biotechnology 2006, 6:33 http://www.biomedcentral.com/1472-6750/6/33
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observed concentrations than standard plastic (Figure 2).
The effect was particularly evident at low concentrations,
and essentially negligible over 100 g.e., as shown in Figure
3. Despite some possible differences on visual inspection
(Figure 1), (for example, conditions 1 and 4 are both low
and are for a particular solution), the Solution effect
proved insignificant at the 95% level of confidence (p =
0.51 for one-way ANOVA supported by a K-W test p-value
of 0.49). These observations were essentially unchanged
on performing 2-way ANOVA for Plastic and Solution
effects, and there was no significant interaction between
the two factors.
These results have practical relevance for performance of
trace DNA measurements. The significant plate effect was
not unexpected, as inter-plate differences are common in
Q-PCR work. In general, calibration plate by plate is to be
recommended; this is, however, normal practice and no
additional recommendation is necessary. The strong effect
of low-retention plastic is, however, likely to be important
for low-level quantification. Based on Figure 3, standard
plastic tubes may give a two-fold reduction in apparent
concentration at low levels, compared to low-retention
plastic. This result is in agreement with a study by Teo et
al  [4], which concluded that siliconised tubes reduced
inconsistencies caused by abstraction of DNA from solu-
tion to the walls of untreated microcentrifuge tubes. Teo
et al also found no significant effect on using carrier DNA
for standard solutions using the Lightcycler. Given the
likelihood that the significant effect of low-retention plas-
tic is related to loss of DNA in standard tubes, and the
improved accuracy at low concentrations, it seems safe to
recommend the use of low-retention plastic when work-
ing with solutions at low DNA concentrations, here below
100 g.e.
Construction of calibration curves at low DNA 
concentration
At higher DNA concentrations (for this assay, at and over
100 target copies per reaction), negative results almost
invariably indicate amplification failure and can justifia-
Boxplot of concentration z score by Condition Figure 1
Boxplot of concentration z score by Condition. Base: 
All observations for concentrations 0.5–1000. See Table 1 
for preparative condition details. Briefly: Conditions 1–3 are 
standard plastic tubes and conditions 4–6 low-retention plas-
tic. Pairs (1,4), (2,5) and 3,6) correspond to water, stabilising 
solution and carrier DNA solutions respectively.
Effect of tube plastic on DNA quantitation Figure 2
Effect of tube plastic on DNA quantitation. Notched 
box plot of concentration z-core against plastic type. 
Notches show approximate 95% confidence intervals for the 
median; non-overlapping notches (as here) indicate significant 
difference. Base: All observations for concentrations 0.5–
1000.BMC Biotechnology 2006, 6:33 http://www.biomedcentral.com/1472-6750/6/33
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bly be removed as invalid observations. At low DNA con-
centrations, however, particularly below about 10 target
copies per reaction, sampling issues mean that a signifi-
cant proportion of the replicate reactions genuinely do
not contain any target. The question then arises of how
best to calibrate, when data contain a significant fraction
of valid negative responses.
Exclusion of the negative observations alone, as at high
concentrations, introduces a marked downward bias in
the average Ct value derived for low-concentration stand-
ards. This is most clearly seen in the appearance of an
upper limit or 'plateau' for mean Ct values at low concen-
trations (Figure 4, filled circles). This plateau effectively
represents Ct value for amplification of a single target
molecule. This plateau precludes discrimination between
samples of different low concentrations. Further, the neg-
ative bias has adverse effects on the complete calibration
curve, the more so as the biased points are at one extreme
of the line and consequently introduce a rotational bias;
compare the solid and dashed lines in Figure 4. Thus at
very low concentrations, omission of individual reactions
with no measurable signal prevents discrimination at low
levels and causes inaccuracy at higher concentrations in
the same assay. Bias introduced by poor reproducibility of
low level calibrators has also recently been reported by Lai
et al [18].
One alternative to omitting negative observations is to
include the non-amplification events occurring in low
level standards in the calculation of the mean Ct values
used for constructing the standard curve, using the (arbi-
trary) limiting value (open circles in Figure 4). The change
in probability of negative responses then leads to an
expectation of non-linear, but monotonic, increase in
mean Ct with reducing concentration, in principle permit-
ting discrimination between very low level samples. Lin-
ear regression is clearly inappropriate (Figure 4, dotted
line), but interpolation using an empirical curve fit to
such data has been previously reported as successful [19].
Effect of low retention plastic by concentration Figure 3
Effect of low retention plastic by concentration. The 
figure shows the ratio of mean predicted concentrations (C) 
for low-retention and standard plastic tubes (the ratio is 
mean(low ret.)/mean(standard)), grouped by nominal con-
centration (copy number). Note that low-concentration 
groups include non-amplification events; the ratios partly 
reflect the reduced incidence of non-amplifications in low-
retention tubes. Means were calculated from all observations 
for concentrations 0.5–1000.
Calibration for low level DNA quantification Figure 4
Calibration for low level DNA quantification. Base: All 
valid observations. The figure shows mean values at each 
concentration with a) (filled circles ●) negative observations 
excluded; b) (open circles o) all values including negative 
observations taken as Ct = 55 (the means coincide at 
log10(C)>0.5). Regression lines are the exclusion-by-sample 
regression (solid line), the line through means with negative 
observations excluded (dashed line) and the line through 
means with negative observations set to Ct = 55 (dotted 
line).BMC Biotechnology 2006, 6:33 http://www.biomedcentral.com/1472-6750/6/33
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However, this approach has several weaknesses. It is very
sensitive to the proportion of negative responses, so
depends on high levels of replication to guarantee near-
monotonic change in observed mean value. The interpo-
lation is arbitrary and cannot readily be generalised to
wide concentration ranges. The coefficients change with
arbitrary changes in the limiting value used. Finally, the
mean Ct value arises from a mixture of quantitative data
and arbitrarily coded qualitative responses, making the
error distribution complex, seriously compromising the
validity of a least-squares approach to interpolation, and
making prediction uncertainties very hard to obtain.
These shortcomings make the approach unsuitable for
routine use.
The approach taken in the present study has therefore
been to remove all data for any standard compromised by
valid negative responses (in this paper this will be referred
to as "exclusion-by-sample"). The rationale is simply that
this eliminates selection bias in the calibration. It is also
very simple to implement, so can be used by a routine lab-
oratory with existing software. The results are shown in
Figure 4, which shows the exclusion-by-sample line for all
data (y = 37.7 - 3.09x) as the solid line.
The approach has the obvious disadvantages of extrapola-
tion to obtain low-concentration values and some loss of
precision. However, extrapolation is valid as long as the
model is sound. The log-linear model is well supported by
the underlying physical process, and effective method val-
idation should in any case confirm linearity over the range
of interest before undertaking analysis. The loss of preci-
sion is not very marked; recall that the lower concentra-
tion samples typically show high variance and should in
any case be down-weighted. Prediction precision can also
be improved by extending the calibration data to higher
concentrations as long as continued linearity is demon-
strated, and also, in principle, by increasing replication
towards the extremes of the calibration range (with cau-
tion at the lower concentrations, as amplification failure
becomes more likely with increased replication). The
most serious practical disadvantage is therefore that it
may not be clear in advance which samples will be
excluded, resulting in wasted effort and resources and,
sometimes, precluding reliable calibration entirely if
insufficient high-concentration samples are included.
There is also some risk of excluding samples that show
negative responses for other reasons.
These latter disadvantages can be ameliorated relatively
easily. Experience or validation studies will show where
the risk of exclusion is sufficiently low to warrant acquisi-
tion of data; this is discussed further below in connection
with detection probabilities. Extending the concentration
range upward to provide more precise extrapolation is
straightforward, and involves no additional effort; the
lowest concentration standards that are at high risk of
exclusion can be replaced by higher-concentration stand-
ards. It is, however, important to identify and remove
aberrant observations at higher concentrations (such as
the single failure at 100 g.e. in the present study). Objec-
tive criteria are important when assessing suspect observa-
tions, and there is little or no standard practice
corresponding to outlier detection in Q-PCR work. It is
accordingly premature to make firm recommendations
here. It may, however, be helpful to note that where a
'true' negative has probability of occurrence of 1% or less,
removal of negative observations prior to analysis would
have little adverse impact on calibration.
Exclusion by sample is nonetheless quite drastic and risks
eliminating a proportion of valid calibrant data, as well as
incurring uncertainty associated with extrapolation. In the
longer term, therefore, there is a need to investigate
approaches that use all the valid data and accommodate
the negative observations without introducing bias. For
example, maximum likelihood fitting is in principle capa-
ble of handling arbitrary error distributions and can
accommodate censored data. Robust regression [20] or
median-based methods could be employed to reduce the
adverse impact of arbitrary assignment of high values, yet
still allow inclusion of all the observations in construction
of calibration curves. The ideal regression method would
also take into account the fact that part of the error arises
from variability in the actual copy number, that is, that
there is significant uncertainty in the independent as well
as the dependent variable. In the mean time, in the
absence of such methods we recommend inclusion of
only those standards in which all replicates yield measur-
able values to ensure that bias is avoided in construction
of calibration curves. If higher concentration standards
have negative reactions that are identified as outliers, the
outliers can still justifiably be excluded.
Quantification of unknown samples
In contrast to the situation in constructing calibration
curves, exclusion of Ct values by sample is not a viable
option when an unknown sample is analysed. Fortu-
nately, calculations are in any case best carried out in the
concentration domain, where one has the option of treat-
ing negative observations as zero concentration. Two
methods for handling negative observations (that is, reac-
tions failing to yield a measurable Ct value) in the calcu-
lation of unknown sample concentration were
accordingly compared to determine the most accurate
approach. The comparison used the replicate data from
the lower concentration standards prepared in low-reten-
tion plastic only, with a calibration model based only on
standards from low-retention plastic. In one approach,
negative reactions were excluded from the calculationBMC Biotechnology 2006, 6:33 http://www.biomedcentral.com/1472-6750/6/33
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entirely, the remaining Ct values converted to concentra-
tion and the average concentration taken. In the other,
negative amplifications were included in the quantifica-
tion by assigning a concentration value of zero for the
observation, and again the resulting individual concentra-
tion estimates were averaged. The first of these approaches
– excluding negative reactions – is expected to introduce
positive bias due to selection for positive reactions only;
increasingly so as the incidence of true negatives increases.
By contrast, although there may be other sources of bias,
assigning a concentration value of zero to non-detects is
expected to introduce negligible additional bias as long as
the distribution of Ct for true positive runs has negligible
density above the Ct threshold.
The results are shown in Table 2. There is a slight positive
bias throughout, perhaps because of slight departures
from linearity, but the results obtained on excluding reac-
tions with Ct = 55 clearly gave consistently higher mean
sample concentrations than assigning zero concentration
to all such values. At 5 target copies and above both meth-
ods gave the same result as all reactions yielded measura-
ble values. The results obtained on setting negative
responses to zero concentration were all closer to the
nominal concentration for the standards. This showed
that, as expected, excluding negative results leads to unde-
sirable positive bias; more importantly, the bias so
induced can be considerable for high proportions of fail-
ure.
The practical implication is that in quantification of
unknown samples at low copy number, valid negative
observations (i.e. those valid observations that have a Ct
equal to the number of cycles run) should be treated as
samples with zero observed concentration. Thus, to calcu-
late the concentration of a particular sample, the mean of
the concentration estimates obtained from Ct values via
the calibration curve should be calculated, including the
negative observations as zero concentration. This allows
all available information on the sample to be included in
the final result, as also detailed recently by Zimmermann
et al [21]. As Table 2 demonstrates, this provides better
estimates of the unknown sample concentration. The
caveat is that negative observations arising through ampli-
fication failure rather than genuine absence of target
should be excluded or otherwise accommodated. As in the
case of calibration curve construction, appropriate criteria
should be applied; again, we note that exclusion of obser-
vations on the basis of low probability of occurrence (e.g.
1% or below) is unlikely to lead to appreciable bias but
will avoid the adverse effects of amplification failure on
higher-concentration samples.
Detection probability and detection limits
Estimates of detection probability at low levels are impor-
tant for several reasons. An understanding of detection
probability is useful in determining the expected fre-
quency of detection for a particular concentration analyte,
when performing a defined number of replicate analyses.
It can assist in deciding whether or not to reject amplifica-
tion failures at low levels, and aid realistic interpretation
of assay results. Performance characteristics such as limit
of detection (sensitivity) for qualitative PCR-based meth-
ods also rely on probability of detection. Finally, under-
standing the detection probability for a single
amplification can assist in deciding optimal replicate
numbers and in choosing minimum concentrations for
reasonable confidence of detection and/or avoidance of
detection failures.
To estimate the number of replicate reactions required to
achieve a particular number of successful amplifications
(at a given probability), the binomial distribution is
Table 2: Comparison of sample quantification methods. 
Concentration/target 
copies μl-1
Number of negative 
reactionsNote 1
Measured concentration
Ct of 55 included (as zero 
concentration)/target copies μl-1
Ct of 55 excluded/target 
copies μl-1
0.5 10 0.66 1.48
1.0 2 1.68 1.89
2.0 3 2.51 3.02
5.0 0 5.28 5.28
10.0 0 10.90 10.90
Note 1: Number of reactions (of 18 replicates) failing to reach fluorescence threshold, and with Ct set to 55.
Results showing the difference in sample concentration determined by either including or excluding amplification reactions with no measurable Ct 
value. The calibration curve was calculated from the low-retention data only, using the exclusion-by-sample method to remove samples with 
missing values, and the interpolated concentrations calculated using the low-retention plastic values only.BMC Biotechnology 2006, 6:33 http://www.biomedcentral.com/1472-6750/6/33
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appropriate. The binomial distribution describes the
probability of ns successes in nt trials (i.e. replicates) with
a probability of success (per trial) of ps. Fortunately,
recourse to the distribution is unnecessary for the special
cases of ns = nt and ns = 0, which are the only cases required
for our purposes. The probability of nt successes in nt trials
(no failures) is  ; that of no successes is  . The
probability of one or more successes (positives) is then 1-
. The number nmin  of replicates required to
ensure a minimum probability pmin of at least one positive
is then given by
nmin = ceiling(log(1-pmin)/log(1-ps))   (1)
where ceiling(x) is the nearest integer greater than or equal
to x.
The calculation requires an estimate of the probability of
detection at the concentration(s) of interest, usually
derived from validation or calibration standard data.
Given sufficient replication, the observed fraction of pos-
itive results at each concentration provides a direct esti-
mate of probability for the particular concentration (a
positive result is considered as the detection of target in a
sample, thus any reaction with a Ct value lower than 55 in
this assay). Use of experimental counts is straightforward.
It is, however, somewhat sensitive to random failures,
leaves little possibility of interpolation to find probabili-
ties at intermediate concentrations, and typically requires
a relatively high number of replicates at each concentra-
tion to provide reliable probability estimates.
Modelling the probability offers a useful alternative. The
detection data is binomial (Positive or Negative), and
logistic regression a widely accepted method of modelling
binomial responses. We therefore applied logistic regres-
sion to the data set above to determine the probability of
target detection across the concentration range.
Logistic regression can be biased by errors at extreme con-
centrations, and PCR data often shows concentrations
spanning several orders of magnitude. Here, the initial fit
against concentration C (omitting C = 0) was relatively
poor due to the amplification failure at 100 g.e. (residual
deviance 183.02 on 250 degrees of freedom, with AIC* of
187.02). With the amplification failure at 100 g.e. omit-
ted, the fit in the concentration domain improved dramat-
ically (residual deviance: 113.57 on 249 degrees of
freedom, with AIC improved to 117.57); this curve was
p(positive) = 1/(1+exp(-(-1.322+1.960C))). The fitted
curve is shown in Figure 5 (solid line). Using the fitted
probabilities in the binomial calculation, replicate num-
bers at the observed concentrations are 6, 3, and 2 for 0.5,
1 and 2 copy numbers, and 1 thereafter, for 95% proba-
bility of at least one positive. This compares well with cal-
culations based on observed fractions.
Ideally, aberrant values should be excluded prior to apply-
ing logistic regression, as here. If that cannot be done with
confidence (for example, for lack of sufficient replication
at any one concentration) we suggest fitting in the log
domain for PCR data to reduce the weight associated with
failures at high concentration. Fitting against log10(C)
provided a good fit to the low-concentration data even
when the amplification failure at 100 g.e. was included
(residual deviance 133.53 on 250 degrees of freedom,
with AIC of 137.53; this should be compared with the
substantially poorer AIC of 187.02 for the initial fit to
concentration C, above). This line was p(positive) = 1/
(1+exp(-(0.854+3.7506*log10(C)))); the curve is shown
as a dashed line in Figure 5. If anything, this curve appears
more realistic on visual inspection, in that it correctly pre-
dicts very low probability at very low concentrations,
where the concentration domain model apparently pre-
dict significant probability of positives. Predicted replica-
tion numbers using this curve were, however, identical to
those previously found.
pn
s
t 1− () p
n
s
t
1− () p
n
s
t
Logistic regression of detection probability Figure 5
Logistic regression of detection probability. Logistic 
regression of a) (solid line) p(positive) vs. concentration C 
with false negative at log10(C) omitted; b) (dashed line) 
p(positive) vs. log10(C) with false negative included. Solid 
points show fraction of positives at each concentration with 
the false negative omitted; the open circle shows the calcu-
lated fraction at log10(C) with the false negative included. The 
apparent lower limit to the solid curve is an artefact of plot-
ting on the log10 axis.BMC Biotechnology 2006, 6:33 http://www.biomedcentral.com/1472-6750/6/33
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Some caution is necessary in modelling probability. Using
a log scale for the independent variable, as here, is essen-
tially an arbitrary choice; although Ct is expected to be lin-
ear in log10(C), there is no ab initio reason to expect
p(positive) to be determined by log10(C) rather than C,
and the logarithmic spacing of concentrations is driven by
practical choice, not necessity. Further, logistic regression
itself, though a widely accepted and successful methodol-
ogy for binary response modelling, the logistic model is
only one possible model for binary responses [22]. Wher-
ever it is used, the fitted model needs to be checked for
quality of fit before being applied to interpolation, and
the most appropriate variant selected. Even then, extrapo-
lation to extreme probabilities is particularly dangerous
unless there is very strong prior evidence that the model
applies.
Overall, both observed counts and logistic regression pro-
vided broadly similar conclusions in this case. Both were
somewhat sensitive to aberrant values; logistic regression
excessively so in the concentration domain. In the log
domain, logistic regression was less affected. The advan-
tages of the logistic regression approach include the gen-
eral smoothing effect of model fitting; the use of the entire
data set in fitting the model, in principle decreasing the
number of replicate measurements required for reliable
prediction at any one concentration; the possibility of
interpolation; and the possibility of estimating uncertain-
ties in the probability estimates from the uncertainties in
fitted coefficients.
Logistic regression can also be applied to the estimation of
analytical sensitivity. In the present study, for example, it
was found that the concentration providing 50% proba-
bility of detection for a single observation (sometimes
taken as an estimate of detection limit, or sensitivity, for
biological assays) corresponded, using the log10(C) curve,
to a value of log10(C) = -0.2275 and an actual concentra-
tion of 0.592 copies, indicating an impressive likelihood
of detectable amplification of a single copy. A similar
application, using probit regression, was recently reported
by Zimmermann et al [21]; in our study, we examined
probit regression in the log10(C) domain for comparison,
and found that it gave a closely similar result to the logis-
tic regression, as expected. Further, logistic regression can
assist in estimating the lowest concentration at which
amplification failure rate remains acceptable, avoiding
wasted resources when employing the recommended
'exclusion by sample' method in calibration. For example,
95% probability of six positives in six replicates requires
an individual run success probability of 0.991 (using the
binomial calculation above, we see that 0.9916 = 0.95);
based on the log-domain logistic regression for our data,
the individual success probability of 0.991 would be
expected at a concentration of about 11 g.e. Note, how-
ever, that lower concentrations also have quite high suc-
cess probabilities (e.g. 0.83 for 5 g.e.); it is therefore not
particularly surprising that we obtained 100% successful
amplifications down to 5 g.e.
Conclusion
Tube plastic had a strong effect on measured DNA concen-
tration at concentrations below 100 g.e., and it is recom-
mended that low-retention plastics be used for DNA
quantification below this level. Neither stabilising solu-
tion nor carrier DNA had a significant effect under the
conditions of this study.
For low-level calibration, it is better to eliminate all Ct val-
ues in a replicate group for any standard concentration
that shows non-detects reasonably attributable (over 1%
probability based on binomial statistics) to sampling
effects, than to eliminate only the non-detects. There is,
however, a need for further work to establish improved
fitting methods in the low-concentration region
In calculating concentrations for low-level test samples
that show appreciable non-detects, concentrations should
be calculated for each replicate, zero concentration
assigned to non-detects, and all resulting concentration
values averaged. Average Ct values should not be used to
estimate concentrations.
Logistic regression was found to be a useful method of
estimating detection probability at low DNA concentra-
tions, provided that measures are taken to remove, or
reduce the effect of, invalid non-amplifications at high
concentrations.
Methods
Calibration standard preparation
A set of experiments was designed to test the influence of
different calibration standard preparation variables on the
sensitivity of low level DNA detection using Q-PCR.
Standards were prepared by serial dilution of human male
genomic DNA to investigate the effects of using low reten-
tion plastics, stabilising solution and carrier DNA. Six dif-
ferent conditions were employed in preparing the
standards as shown in Table 1. Regular or low retention
plastic microtubes were used with water, a commercially
produced stabilising solution (Cambio, UK) or carrier
DNA solution (herring sperm DNA, Sigma, UK, at 10 μg/
ml) as diluent for the calibration standards.
Standards at eight concentrations were prepared from a
DNA stock solution (Promega, UK) at a concentration of
5000 genome equivalents (g.e.) per μl. The stock was
quantified with PicoGreen® intercalating dye (Molecular
Probes, Netherlands) on a fluorescence plate reader, using
a commercially purified DNA Standard Solution (Cam-BMC Biotechnology 2006, 6:33 http://www.biomedcentral.com/1472-6750/6/33
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bio, UK) prepared gravimetrically. Results were expressed
as genome equivalents based on the calculated concentra-
tion, using the conversion factor of 6.6 pg of DNA per dip-
loid genome. The stock DNA was also measured on an
ND-1000 spectrophotometer (NanoDrop Technologies)
to verify the PicoGreen® value. Standard curves in the
range 1000 to 0.5 g.e./μl, and negative controls (contain-
ing only the appropriate diluent) were prepared in vol-
umes of between 200–1000 μl. Previous work
demonstrated that amplification sensitivity and accuracy
improved for low concentration standards prepared in rel-
atively large volumes (200–1000 μl), compared to smaller
ones (<50 μl, data not shown). Each point of the standard
curve was assayed in duplicate to enable the 6 different
standard preparation conditions to be compared directly
on one reaction plate. The whole assay was repeated 3
times to produce replicate sets of data for comparison,
and Ct value was the measurand used to assess all stand-
ard DNA preparation conditions. In order to complete
analysis of 3 plates in one day using the same analyst, the
dilutions were prepared late the day before and stored at
+4°C overnight.
Q- PCR assay
The Q- PCR was performed on the PRISM® 7700 Sequence
Detector System (Applied Biosystems, UK) using the 5'-
nuclease assay with a dual labelled fluorogenic "TaqMan"
probe. All oligonucleotides were designed according to
the guidelines recommended by Applied Biosystems. A
coding region of the male specific SRY gene was chosen as
the amplification target and the primer and probe
sequences were as follows:
Forward primer: 5'CGATCAGAGGCGCAAGATG3'.
Reverse primer: 5'TGGTATCCCAGCTGCTTGCT3'.
Probe: 5'-VIC-TCTAGAGAATCCCAGAATGCGAAACTCA-
GAGA-TAMRA-3'
The PCR for each 25 μl reaction was composed of: For-
ward primer 450 nM (Sigma, UK), reverse primer 450 nM
(Sigma, UK), TaqMan probe 225 nM (Applied Biosys-
tems, UK), 1 × Excite PCR mix (Biogene, UK) and 1 μl of
DNA in a total volume of 25 μl. Each PCR was run for 55
cycles (50°C, 2 min, UNG activation; 95°C, 10 min,
denaturation, followed by 55 cycles of 95°C, 5 sec and
60°C, 1 min, amplification). Initial treatment of the raw
data was carried out using the Applied Biosystems SDS
software.
Contamination was minimised by preparing reaction
mixtures in a dedicated clean room with reagents aliq-
uoted into single use volumes. The 1 × reaction mix con-
tained Uracil-N-Glycosylase (UNG) to prevent carry-over
contamination between PCR reactions and the DNA was
added in a separate template addition area. The quality of
each standard curve was assessed by checking the negative
controls for amplification signals. If any false positive sig-
nals were detected, data from the affected curve was dis-
carded and the run repeated (which was necessary for one
8-point standard curve in this set of experiments).
Statistical methods
The raw Ct values [see Additional file 1] were not very
amenable to analysis for preparation effects in production
of the DNA standards. The variances differed substantially
between concentrations (Levene's test gave a p-value of
5.9 × 10-14), and the values assigned to non-amplifica-
tions (Ct = 55) were essentially arbitrary, generating arbi-
trary non-normality and effectively placing the data on an
ordinal rather than interval scale. These difficulties were
addressed by, first, working in the concentration domain
and then z-scoring by concentration. The procedure was as
follows: All valid log(concentration)/Ct values were fitted
using the exclusion-by-sample method. Sample concen-
trations were calculated from the fit coefficients. Samples
with Ct = 55 were set to zero concentration. The resulting
concentration estimates were z-scored by group, using
robust estimates of location and scale (Huber proposal 2,
following ([23]). Specifically, the concentrations were
converted to z-scores using zij = (xij -  j)/ j where  j is the
Huber estimate of location for concentration j, and  j the
corresponding robust standard deviation. z-Scoring by
concentration was chosen instead of more general trans-
formation or scaling because a) the dependence of vari-
ance on concentration was not straightforward and b) as
well as standardising the variance, z-scoring removed the
primary effect of concentration which would otherwise
have to be controlled for in testing the effects of interest.
The reason for using robust scaling parameters in z-scor-
ing was to reduce any adverse effects of extreme. Levene's
test showed, as expected, that the z-score variances were
essentially identical across concentrations.
The scores remained non-normally distributed for some
low concentrations, but the overall distribution was not
grossly non-normal. To confirm that the findings were not
critically dependent on normality assumptions, any sig-
nificant one-way ANOVA was followed up by a Kruskal-
Wallis (K-W) test. The Kruskal-Wallis tests confirmed the
ANOVA result in every case.
The aberrant negative observation at 100 g.e. was
excluded from the analysis.
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In addition, logistic regression was used to predict the
probability of detection of a positive signal at all target
concentrations. Detection positives were judged as reac-
tions with Ct<50.
Software
Statistical analysis was carried out in R version 2.1.0 [24]
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